ctrl K

Watchlist Price Alert

Immix Biopharma Inc. (IMMX)

NASDAQ: IMMX · Real-Time Price · USD

2.28

-0.12 (-5.00%)

At close: Jun 17, 2025, 3:43 PM

2.28

0.00%

After-hours: Jun 17, 2025, 04:04 PM EDT

Immix Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	17.68M	17.51M	13.44M	17.64M	391.09K	734.01K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	20.42K	87.23K	6.72K	-0.00	-0.00	-0.00
Receivables	1.97M	1.17M	255.71K	25.72K	127.44K	175.75K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	32.27K	44.58K	78.07K	n/a	n/a	n/a
Total Current Assets	20.2M	19.79M	14.9M	18.19M	532.24K	933.26K
Property-Plant & Equipment	2.73M	50.18K	3.56K	5.7K	7.36K	9.68K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	2.75M	137.41K	10.28K	5.7K	7.36K	9.68K
Total Assets	22.95M	19.93M	14.91M	18.19M	539.6K	942.94K
Account Payables	5.39M	1.43M	143.07K	142.94K	252.34K	247.54K
Deferred Revenue	n/a	n/a	n/a	n/a	342.84K	n/a
Short-Term Debt	65.22K	n/a	n/a	50K	4.1M	4.1M
Other Current Liabilities	3.23M	n/a	n/a	n/a	575K	n/a
Total Current Liabilities	8.69M	3.72M	1.27M	202.04K	5.27M	4.59M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	475K	n/a	n/a	n/a
Total Long-Term Liabilities	1.01M	n/a	475K	n/a	n/a	n/a
Total Liabilities	9.7M	3.72M	1.75M	202.04K	5.27M	4.59M
Total Debt	1.07M	n/a	n/a	50K	4.1M	4.1M
Common Stock	2.76K	2K	1.4K	1.32K	338.00	338.00
Retained Earnings	-75.02M	-53.41M	-37.99M	-29.76M	-5.37M	-4.22M
Comprehensive Income	-1.06K	134.67K	87.02K	125.41K	131.86K	68.22K
Shareholders Equity	13.25M	16.41M	13.16M	17.99M	-4.73M	-3.65M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a